Appeal no. 55 of 2012, was a non-executive
independent director of Ranbaxy Laboratories Limited (Ranbaxy) for the period from
2
January ... December 18, 2008. Ranbaxy is the parent company of Solrex
Pharmaceuticals Limited (Solrex). Ranbaxy is also the holding company of Rexcel
Pharmaceutical Limited (Rexcel
March, 2007
ORDER
V.K. Chopra, Member
1. BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to as "Ranbaxy") is engaged mainly ... manufacturing and marketing of pharma products. The price of the scrip of Ranbaxy moved up significantly from Rs. 270/- in January 1999 to about
March, 2007
ORDER
V.K. Chopra, Member
1.0 BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to as "Ranbaxy") is engaged mainly ... manufacturing and marketing of pharma products. The price of the scrip of Ranbaxy moved up significantly from Rs. 270/- in January 1999 to about
March, 2007
ORDER
V.K. Chopra, Member
1. BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to as "Ranbaxy") is engaged mainly ... manufacturing and marketing of pharma products. The price of the scrip of Ranbaxy moved up significantly from Rs. 270/- in January 1999 to about
March, 2007
ORDER
V.K. Chopra, Member
1.0 BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to as "Ranbaxy") was incorporated in June ... manufacturing and marketing of pharma products. The price of the scrip of Ranbaxy had moved up significantly from Rs. 270/- in January 1999 to about
affairs relating to buying, selling and dealing in the shares of Ranbaxy Laboratories Ltd (hereinafter referred to in short as "Ranbaxy") against many ... SEBI Registration no. INB010752633).
1.2 The price of the scrip of Ranbaxy had moved up significantly from Rs. 270/-in January 1999 to about
entities including the broker Mr Shyam Sundar Dalmia in the shares of Ranbaxy Laboratories Ltd. (hereinafter referred to in short as "Ranbaxy ... price of the scrip of Ranbaxy moved up significantly from Rs. 270/- in January 1999 to about Rs. 1200/- in October 1999 accompanied with significant
affairs relating to buying, selling and dealing in the shares of Ranbaxy Laboratories Ltd (hereinafter referred to in short as "Ranbaxy") on observing ... significant increase in the price and volume in the scrip of Ranbaxy particularly in the Stock Exchange, Mumbai (BSE), National Stock Exchange (NSE) and Calcutta
March, 2007
ORDER
V.K. Chopra, Member
1.0 BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to as "Ranbaxy") was incorporated in June ... Ranbaxy is engaged mainly in the business of manufacturing and marketing of pharma products. Securities and Exchange Board of India (hereinafter referred to in short
March, 2007
ORDER
V.K. Chopra, Member
1.0 BACKGROUND
1.1 Ranbaxy Laboratories Ltd. (hereinafter referred to in short as "Ranbaxy") was incorporated ... June 1961. Ranbaxy is engaged mainly in the business of manufacturing and marketing of pharma products. The price of the scrip of Ranbaxy moved
